著書・総説
1. Kawana T, Chen JT, Yoshikawa H, Yoshida R, Nagano M and Sakamoto S:
Clinical and virological aspects of female genital herpes in Japan, In: Shiota H., Cheng
YC and Prusoff WH (ed), Herpesvirus, Excerpta Medica, Amsterdam, 1982；571：
339-350.
2. Yoshikawa H and Kawana T: Human papillomavirus DNA sequences in cervicalcondylomata.

In: Kurihara S (ed), Cervical Pathology and Colposcopy, Elsevier

Science Publishers BV, Amsterdam, 1985：111．
3. Kuwabara Y, Yoshikawa H, Mizuno M and Sakamoto S. Paraaortic
lymphadenectomy in gynecologic cancer. In: Takagi S (ed), Gynecologic Oncology,
Surgery and Urology, Excerpta Medica, Amsterdam, 1987：844-849．
4. Yoshikawa H, Onda T, Yasugi S, Nakagawa S and Taketani Y: Management of
HPV-positive CIN patients; HPV type and the risk of progression of CIN to cancer. In:
Saifuddin AB, Affandi B and Wiknjosastro GH (ed), Women's Health: Recent
Advances in the Asia-Oceania Region, Yayasan Bina Pustaka Sarwono Prawirohardjo,
Jakarta, 1995：361-363．
5. Kanda T, Kawana K, Yoshikawa H: Human papillomavirus type 16 capsid proteins:
Immunogenecity and possible use as prophylactic vaccine antigens. Ed. Cheng R.H. andMiyamura T. Structure-based study of viral replication. World Scientific Publishing(London). pp539-552, 2008
6. Onda T, Yoshikawa H. Neoadjuvant chemotherapy for advanced ovarian cancer:
overview of outcomes and unanswered questions. Expert Review of Anticancer
Therapy, 11(7): 1053-1067, 2011.

7. Onda T, Konishi I, Yoshikawa H, Kamura T. The History of the Gynecologic Cancer
Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG). Jpn J Clin Oncol,
41(10): 1156-1161, 2011.
8. Matsumoto K, Yoshikawa H. Human papillomavirus infection and risk for cervicalcancer in Japan. J Obstet Gynaecol Res. 39(1):7-17, 2013
原著論文
1. Kawagoe K, Yoshikawa H, Kawana T and Mizuno M. Verrucous carcinoma of theuterine cervix. Acta Obstet Gynecol Jpn

36：617-622, 1984．

2. Yoshikawa H, Matsukura T, Yamamoto E, Kawana T, Mizuno M and Yoshiike K.
Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas fromJapan:age of patients and histilogical type of carcinomas.

Jpn J Cancer Res 76：

667-671, 1985．
3. Yoshikawa H, Matsukura T, Yoshiike K, Yamamoto E, Kawana T and Mizuno, M.
Human papillomavirus DNA in female condylomata. Acta Obstet Gynecol Jpn 1985；
37：1225-1230．
4. Matsukura Y, Kanda T, Furuno A, Yoshikawa H, Kawana T and Yoshiike K.
Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA
from a cervical carcinoma.

J Virology

58：979-982, 1986．

5. Lim-Tam SK, Yoshikawa H, Sng IT, de Villiers EM, zur Hausen H, Ho TH andYoong T. Human papillomavirus in dysplasia and carcinoma of the cervix in Singapore.
Pathology

20：317-319, 1988．

6. Yokota H, Yoshikawa H, Shiromizu K, Kawana T and Mizuno M. Detection ofhuman papillomavirus type 6/11, 16 and 18 in exfoliated cells from the uterine cervicesof Japanese women with and without lesions.

Jpn J Cancer Res 81：896-901, 1990．

7. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M,Yoshikura H and Iwamoto A:
Amplication and typing of multiple cervical cancer-associated human papillomavirus
DNAs using a single pair of primers. Int J Cancer 1990；45：990-992．
8. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H and Iwamoto A.
Detection and typing of multiple genital human papillomaviruses by DNA amplification
with Consensus primers.

Jpn J Cancer Res

82：524-531, 1991．

9. Hashido M, Kanda T, Zanma S, Watanabe S, Komiyama N, Yoshikawa H,
Yamaguchi N, Kawana T, and Yoshiike K. Detection of human antibody against thehuman papillomavirus type-16 E7 protein.

Jpn J Cancer Res

82：1406-1412,

1991．
10. Kanda T, Onda T, Zanma S, Yasugi T, Furuno A, Watanabe S, Kawana T, Sugase
M, Ueda K, Sonoda T, Suzuki S, Yamashiro T, Yoshikawa H and Yoshiike K.
Independent association of antibodies against human papillomavirus type 16 E1/E4 andE7 proteins with cervical cancer.

Virology 190：724-732, 1992．

11. Iwamoto A, Yoshikawa H, Kitagawa K, Igarashi H, Kawana T and Yoshikura H.
Short sequence in L1 region of human papillomaviruses correlates with clinical picturesand grouping by cross-hybridization.

Jpn J Cancer Res

83：315-319, 1992．

12. Yokota H, Yoshikawa H, Yasugi T and Mizuno M. Parenchymal liver metastasis of
the epithelial ovarian cancer. Cancer Reseach, Therapy and Control

1：29-32, 1992

13. Onda T, Kanda T, Zanma S, Yasugi T, Watanabe S, Kawana T, Ueda K, Yoshikawa
H, Taketani Y and Yoshiike K. Association of the antibodies against humanpapillomavirus 16 E4 and E7 proteins with cervical cancer positive for humanpapillomavirus DNA. Int J Cancer 54：624-628, 1993．
14. Goto T, Yamaguchi Y, Hashido M, Yoshikawa H and Kawana T. Diagnosis ofgenital Herpes by polymerace chain reaction amplification.

Microbiol Immunol 37：

987-990, 1993．
15. Suzuki N, Yano T, Nakazawa N, Yoshikawa H and Taketani Y: A possible role ofestrone produced in adipose tissues in modulating postmenopausal bone density.
Maturitus

22：9-12, 1995．

16. Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T.
Mutational Analysis of human papillomavirus type 16 E6 protein: Transforming
function for human cells and degradation of p53 in vitro.

Virology 212：535-542,

1995．
17. Nagano H, Yoshikawa H, Kawana T, Yokota H, Taketani Y, Igarashi H, Yoshikura
H and Iwamoto A. Association of multiple human papillomavirus types with vulvar
neoplasias. J Obstet Gynecol Res

22：1-8, 1996．

18. Kitagawa K, Yoshikawa H, Onda T, Kawana T, Taketani Y, Yoshikura H and
Iwamoto A. Genomic organization of human papillomavirus type 18 in cervical cancer
specimens. Jpn J Cancer Res.

87：263-268, 1996．

19. Yamada M, Tomida A, Yoshikawa H, Taketani Y and Tsuruo T. Increased
expression of Thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistanthuman cancer cell lines.

Clin Cancer Res

2：427-432, 1996．

20. Kikuchi A, Okai T, Kobayashi K, Yoshikawa H, Schiromizu K, Matsuzawa M and
Taketani Y. Intracervical ultrasonography with a high-frequency Miniature probe; Anew diagnostic method for early invasive cervical cancer.

Radiology

198：411- 413,

1996．
21. Matsumi H, Kozuma S, Baba K, Kobayashi K, Yoshikawa H and Taketani Y.
Three-dimentional ultrasound is useful in diagnosing the fetus with abdominal wall
defect. Ultrasound in Obstet and Gynecol

8：356-358, 1996．

22. Morita Y, Tsutsumi O, Kuramochi K, Momoeda M, Yoshikawa H and Taketani Y.
Successful laparoscopic management of primary abdominal pregnancy. Hum
Reproduction

11：2546-2547, 1996．

23. Onda T, Yoshikawa H, Yokota H, Yasugi T and Taketani Y. Assessment ofmetastases of aortic and pelvic lymph nodes from epithelial ovarian carcinoma; A
Proposal for Essential Sites for Node Biopsy.

Cancer 78：803-808, 1996．

24. Kawana K, Yoshikawa H and Sata T. Post-partum detection of varicella-zoster virus
DNA in the placenta.

Int. J. Gynecol. Obstet.

55：165-166, 1996．

25. Nakagawa S, Yoshikawa H, Onda T, Kawana T, Iwamoto A and Taketani Y. Typeof human papillomavirus is related to clinical features of cervical cancer.

Cancer

78：1935-1941, 1996．
26. Kawana K, Yoshikawa H, Yokota H,

Onda T, Nakagawa K, Tsutsumi O and

Taketani Y. Successful treatment using gamma-knife radiosurgery for brain metastases
from ovarian cancer.

Gynecol. Oncol.

65：357-359, 1997．

27. Yamada M, Tomida A, Yoshikawa H, Taketani Y and Tsuruo T. Overexpression ofthioredoxin does not confer resistance to cisplatin in transfected human ovarian andcolon cancer cell lines. Cancer Chemother. Pharmacol.

40：31-37, 1997．

28. Jimbo H, Hitomi Y, Yoshikawa H, Yano T, Momoeda M, Tsutsumi O, Sakamoto, A,
Taketani Y and Esumi H. Evidence for monoclonal expansion of epithelial cells in
ovarian endometrial cysts.

Am J Pathol

150：1173-1178, 1997．

29. Ayabe T, Tsutsumi O, Sakai H, Yoshikawa H, Yano T, Kurimoto F and Taketani Y.
Increased circulating levels of insulin-like growth factor-I and decreased circulatinglevels of insulin-like growth factor binding protein-1 in postmenopausal women withendometrial cancer.

Endocrine J

44：419-424, 1997．

30. Terakawa N, Kigawa J, Taketani Y, Yoshikawa H, Yajima A, Noda K, Okada H,
Kata J, Yakushiji M, Tanizawa O, Fujimoto S, Nozawa S, Takahashi T, Hasumi, K,
Furuhashi N, Aono T, Sakamoto A, Furusato M and the Endometrial Hyperplasia Study
Group. The behavior of endometrial hyperplasia: A prospective study.
Gynaecol. Res

J Obstet

23：223-230, 1997．

31. Hamai Y, Fujii T, Nishina H, Kozuma S, Yoshikawa H and Taketani Y. Differential
clinical courses of pregnancies complicated by diabetes insipidus which dose, or not,pre-date the pregnancy. Hum Reproduction

12：1816-1818, 1997．

32. Ryo E, Okai T, Namba S, Okagaki R, Kikuchi A, Kozuma S, Yoshikawa H and
Taketani Y. Successful thoracoamniotic shunting using a double-flower catheter in acase of fetal cystic adenomatoid malformation associated with hydrops andpolyhydramnions. Ultrasound in Obstetrics and Gynecology

10：293-296, 1997．

33. Harada I, Tsutsumi O, Takai Y, Iida T, Sakai M, Yoshikawa H and Taketani Y.
DNA polymorphism analysis of a case of complete hydatidiform mole coexisting with afetus. Hum Reproduction

12：2563-2566, 1997．

34. Matsumoto K, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T.

Antibodies tohuman papillomaviruses 16, 18, 58, and 6b major capsid proteins among Japanese
females.

Jpn J Cancer Res

88：367-375, 1997．

35. OndaT, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, Ozaki Y,
Murakami A, Ueda K and Taketani Y. Treatment of node-positive endometrial cancer
with complete node dissection, chemotherapy and radiation therapy. Br J Cancer

75：

1836-1841, 1997．
36. Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A and Taketani Y. Prevalenceof ovarian endometriosis in epithelial ovarian cancer.

Int J Gynecol Obstet

55：

165-166, 1997．
37. Kawana K, Matsumoto K, Yoshikawa H, Taketani Y, Kawana T, Yoshiike K and
Kanda T. A surface Immunodeterminant of human papillomavirus type 16 minor capsid
protein L2.

Virology

245：353-359, 1998．

38. Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J andKato S. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor
hrough its coiled-coil domain. Biochem Biophys Res Commun

245：900-905, 1998．

39. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y andNakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 andrisk of cervical cancer in Japanese patients with HPV16/18 infection

Cancer Res 58：

4585-4586, 1998．
40. Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M,
Matsumoto K and Taketani Y. Patients with ovarian carcinoma upstaged to Stage III
after systematic lymphadenectomy have similar survival to Stage I/II patients andsuperior survival to other Stage III patients. Cancer 83：1555-1560, 1998．

41. Kawana K, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T. In vitro
construction of pseudovirions of human papillomavirus type 16: Incorporation ofplasmid DNA into reassembled L1/L2 capsids. J Virology

72：10298-10300, 1998．

42. Oda K, Shiratsuchi T, Nishimori H, Inazawa J, Yoshikawa H, Taketani Y,
Nakamura Y, and Tokino T. Identification of BAIAP2 (BAI-associated protein 2), a
novel human homologue of hamster IRSp53, whose SH3 domain interacts with thecytoplasmic domain of BAI1.

Cytogenet Cell Genet

84：75-82, 1999．

43. Yamada M, Tomida A, Yun J, Cai B, Yoshikawa H, Taketani Y and Tsuruo T.
Cellular sensitization to cisplatin and carboplatin with decreased removal of
platinum-DNA adduct by glucose-regulated stress. Cancer Chemotherapy andPharmacology

44：59-64, 1999．

44. Matsumi H, Kozuma S, Osuga Y, Yano T, Yoshikawa H, Tsutsumi O and Taketani
Y. Ultrasound imaging of pseudomyxoma peritonei with numerous vesicles in asctic
fluid. Ultrasound in Obstetrics and Gynecology 1999；13：378-379．
45. Yano T, Jimbo H, Yoshikawa H, Tsutsumi O and Taketani Y. Molecular analysis ofclonality in ovarian endometrial cysts. Gynecolgic and Obstetric Investigation 1999；
47：41-46．
46. Mishima M, Yano T, Jimbo H, Yano N, Morita Y, Yoshikawa H, Schally AV and
Taketani Y. Inhibition of human endometrial cancer cell growth in vitro and in vivo bysomatostatin analog RC-160. Am J Obstet Gynecol

181：583-590, 1999．

47. Jimbo H, Hitomi Y, Yoshikawa H, Yano T, Momoeda M, Yasugi T, Taketani Y,
and Esumi, H. Clonality analysis of bilateral ovarian endometrial cysts. Fertility and
Sterility 72：1142-1143, 1999．

48. Nakagawa S, Yoshikawa H, Kimura M, Kawana K, Matsumoto K, Onda T,
Kino N, Yamada M, Yasugi T and Taketani Y. A possible involvement of aberrant
expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of theuterine cervix. Br J Cancer

79：589-594, 1999．

49. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N,
Kawana K, Kozuka T, Nakagawa K, Aoki M and Taketani Y. Elderly Japanese womenwith cervical carcinoma show higher proportions of both intermediate-risk humanpapillomavirus types and p53 mutations. Br J Cancer 79：1139-1144, 1999．
50. Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Nozawa S,
Hoshiai H, Shiromizu K, Kanda T and Taketani Y. Balance of IgG subclass toward
human papillomavirus type 16 (HPV16) L1-capsids is a possible predictor for the
regression of HPV16-positive cervical intraepithelial neoplasia.
Res Commun

Biochem Biophys

258:128-131, 1999

51. Kawana K, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T. Common
netralizing epitope in minor capsid protein L2 of human papillomaviruses 16 and 6. J
Virology

73：6188-6190, 1999．

52. Nagata C, Shimizu H, Yoshikawa H, Noda K, Nozawa S, Yajima A, Sekiya S,
Sugimori H, Hirai Y, Kanazawa K, Sugase M and Kawana T. Serum carotenoid andvitamins and risk of cervical dysplasia from a case control study in Japan. Br J Cancer
81：1234-1237, 1999．
53. Yoshikawa H, Nagata C, Noda K, Nozawa S, Yajima A, Sekiya S, Sugimori H,
Hirai Y, Kanazawa K, Sugase M, Shimizu H and Kawana T. Human papillomavirus
infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J
Cancer 80：621-624, 1999．

54. Minaguchi T, Mori T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y andNakamura Y. Growth suppression of human ovarian cancer cells by adenovirusmediated transfer of the PTEN gene. Cancer Res

59：6063-6067, 1999．

55. Matsumoto K, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T.
DNA vaccination of mice with plasmid expressing human papillomavirus 6 major
capsid protein L1 elicits type-specific antibodies neutralizing pseudovirions constructedin vitro. J Med Virology 60：200-204, 2000．
56. Hiroi M, Momoeda M, Yamauchi N, Abe Y, Yoshikawa H, Tsutsumi O and
Taketani Y. An earlier menopause as clinical manifestation of granulosa-cell tumor: Acase report. J Obstetrics and Gynecology Research

26：9-12, 2000．

57. Kozuka T, Aoki Y, Nakagawa K, Ohtomo K, Yoshikawa H, Matsumoto K,
Yoshiike K and Kanda T. Enhancer-promoter activity of human papillomavirus type 16
long control region isolated from cell lines SiHa and Caski and cervical cancer biopsies.
Jpn J Cancer Res

91：271-279, 2000．

58.Nakagawa, S, Yoshikawa H, Yasugi T, Kimura M, Kawana K, Matsumoto K,
Yamada M, Onda T, Taketani Y. Ubiquitous presence of E6 and E7 transcripts inhuman papillomavirus-positive cervical carcinomas regardless of its type.

J Med

Virol 62: 251-258, 2000
59.Matsumoto, K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S,
Hirai Y, Kukimoto I, Kanda T and Taketani Y Enhanced oncogenicity of humanpapillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156:
159-165, 2000
60.Yano T, Radulovic S, Osuga Y, Kugu K, Yoshikawa H, Taketani Y, Schally AV.
Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin
analog RC-160. Oncology 59 Suppl 1:45-49, 2000.

61.Yoshikawa H, Jimbo H, Okada S, Matsumoto K, Onda T, Yasugi T, Taketani Y.
Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50 Suppl
1:11-17, 2000.
62.Ishiwata I, Yoshikawa H, Nakagawa S, Kiguchi K, Ishikawa Human papillomavirus
types 56 and 59 in novel cervical cancer cell lines.
Hum Cell 13(1):55-56, 2000.
63. Kawana K, Kawana Y, Yoshikawa H, Taketani Y, Yoshiike K and KandaT: Nasal
immunization of mice with peptide having a cross-neutralization epitope on minor
capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal
antibodies. Vaccine 19 (11-12); 1496-1502, 2001
64.Kawana Y, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T:Human
papillomavirus type 16 minor capsid protein L2 N-terminal region containing acommon neutralization epitope binds to the cell surface and enters the cytoplasm. J
Virology 75 (5): 2331-2336, 2001
65.Ryo E, Yorinaga Y, Nagasaka T, Yoshikawa H and Taketani Y:
Tumor cell spillage to the vaginal cavity and vaginal stump during the surgery ofendometrial carcinoma. Acta Obstet Gynecol Scand 80 (4): 364-367, 2001
66.Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, Hatae M,
Kodama S, Kuzuya K, Sato S, Nishimura T, Hiura M, Nakano H, Iwasaka T, Miyazaki
K and Kamura T: Conservative therapy for adenocarcinoma and atypical endometrial
hyperplasia of the endometrium in young woman: central pathologic review andtreatment outcome. Cancer Lett 167; 39-48, 2001
67.Akahira J, Yoshikawa H, Shimizu Y, Tsunematsu R, Hirakawa T, Kuramoto H,
Shiromizu K, Kuzuya K, Kamura T, Kikuchi Y, Kodama S, Yamamoto K and Sato S:

Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective
study. Gynecol Oncol 81: 398-403, 2001
68.Hiroi H, Yasugi T, Matsumoto K, Fujii T, Watanabe T, Yoshikawa H and Yaketani Y:
Mucinous adenoarcinoma arising in a neovagina using the sigmoid colon thirty years
after operation: A case report. J Surgical Oncol 77: 61-64, 2001
69.Xin CY, Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M,
Nozawa S, Sekiya S, Hirai Y, Shiromizu K, Fujii T, Taketani Y:
Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese womenwith cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic
potential. Cancer Lett 170; 19-24, 2001
70.Minaguchi T, Yoshikawa H, Oda K, Ishino T, Yasugi T, Onda T, Nakagawa S,
Matsumoto K, Kawana K, Taketani Y: PTEN mutation located only outside exons 5, 6
and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin
Cancer Res 7; 2636-2642, 2001
71.Takanami-Ohnishi Y, Asada S, Tsunoda H, Fukamizu A, Goto K, Yoshikawa H,
Kubo T, Sudo T, Kimura S, Kasuya Y: Possible involvement of p38 mitogen-activatedprotein kinase in decidual function in parturirion.Biochem Biophys Res Commun 288,
1155-1161, 2001
72.Watanabe H, Hamada H, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T.
Evidence for an association of the R485K polumorphism in the coagulation factor V
gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes.
Thromb Haemost 86, 1594-1595, 2001
73.Hashimoto K, Kato K, Imamura A, Yoshikawa H, Taketani Y, Esumi H.
5-amino-4-imidazolecarboxamide riboside confers strong tolerance to glucose
starvation in a 5’-AMP-activated protein kinase-dependent fashion. Biochem Biophys
Res Commun, 290(1): 263-267, 2002.

74.Ichikawa Y, Tsunoda H, Takano K, Oki A, Yoshikawa H. Microsatellite instability
and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium,
endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis
colorectal cancer patient. Jpn J Clin Oncol, 32(3): 110-112, 2002
75.Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa K, Yoshikawa H, Arinami
T. Association analysis of nine missense polymorphisms in the coagulation factor V
gene with severe preeclampsia in pregnant Japanese women. J Hum Genet, 47:
131-135, 2002
76.Hasumi Y, Mizukami H, Urabe M, Kohno T, Takeuchi K, Kume A, Momoeda M,
Yoshikawa H, Tsuruo T, Shibuya m, Taketani Y, Osawa K. Soluble FLT-1 expression
suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Cancer Res,
62(7): 2019-2023, 2002.
77.Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Kawana
K, Minaguchi T, Oda K, Hasumi Y and Taketani Y. Distinct lymphatic spread ofendometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer
Lett, 180(1): 83-89, 2002
78.Okada S, Tsuda H, Ohmi K, Kasamatsu T, Tamada T, Tsunematsu R, Sumi M,
Tokuuye K, Yoshikawa H and Hirohsashi S. Immature glandular features in squamouscell carcinoma of the uterine cervix as an independent indicator of resistance toradiotherapy. Int J Gynecol Cancer, 12(3), 277-285, 2002
79.Tanaka Y.O, Shigemitsu S, Nagata M, Shindo M, Okayomo Y, Yoshikawa H and Itai
Y. A decidualized endometrial cyst in a pregnant woman: a case observed with asteady-state free precession imaging sequence. Magnetic Resonance Imaging, 20,
301-304, 2002

80.Okada S, Tsuda H, Takarabe T, Yoshikawa H, Taketani Y and Hirohashi S. Allelotype
analysis of common epithelial ovarian cancers with special reference to comparison
between clear cell adenocarcinoma with other histological types. Jpn J Cancer Res, 93,
798-806, 2002
81.Kawana K, Yasugi T, Kanda T, Kawana Y, Hirai Y, Yoshikawa H and Taketani Y.
Neutralizing antibodies against oncogenic human papillomavirus as a possible
determinant of the fate of low-grade cervical intraepithelial neoplasia. BBRC, 296(1),102-105, 2002
82.Ogura T, Hamada H, Obata-Yasuoka M, Okuno S, Fujiki Y, Yamada N, Sohda S andYoshikawa H. Antepartum assesment of fetal cystic lymphangioma by magnetic
resonance imaging. Gynecol Obstet Invest, 53(4), 237-9, 2002
83.Obata-Yasuoka M, Ba-Thein W, Tsukamoto T, Yoshikawa H and Hayashi H. Vaginal
Escherichia coli share common virulence factor profiles, serotypes and phylogeny withother extraintestinal E. coli. Microbiology 148(9), 2745-52, 2002
84.Horie K, Tomida A, Sugimoto Y, Yasugi T, Yoshikawa H, Taketani Y and Tsuruo
T.SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex
formation induced by camptothecin.
Oncogene 2002, 21(52):7913-22.
85.Kiguchi K, Ishiwata I, Tokieda Y, Iguchi M, Ishiwata C, Iwata M, Ishizuka B,
Yoshikawa H, Tachibana T, Hashimoto H and Ishikawa H. Establishment andcharacterization of a lymphoepithelial-like carcinoma cell line (HUUCLEC) derived
from the human uterine cervix. Hum Cell 2002, 15(2):97-102.
86. Kiguchi K, Ishiwata I, Ishiwata C, Iwata M, Ishizuka B, Yoshikawa H, Tachibana T,
Hashimoto H and Ishikawa H. Establishment and characterization of two squamous cell
carcinoma cell lines (HYVC and HMVC) derived from vulva. Hum Cell 2002,
15(4):207-214

87.Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A,
Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y and Kanda T. IgG antibodies to humanpapillomavirus 16, 52, 58, and 6 L1 capsids: Case-control study of cervicalintraepithelial neoplasia in Japan.
J Med Virol 2003, 69(3):441-6.
88.Ohara K, Tanaka YO, Tsunoda H, Sugahara S, Hashimoto T, Kagei K, Tokuuye K,
Akine Y, Yoshikawa H and Itai Y. Nonoperative assessment of nodal status for locallyadvanced cervical squamous cell carcinoma treated by radiotherapy with regard topatterns of treatment failure.
Int J Radiat Oncol Biol Phys 2003, 1;55(2):354-61.
89.Nakauchi-Tanaka T, Sohda S, Someya K, Kono K, Hamada H and Yoshikawa H.
Acquired Haemophilia due to factor VIII inhibitors in ovarian hyperstimulation
syndrome: case report. Human Reproduction 2003, 18(3): 506-508.
90.Arimoto T, Katagiri T, Oda K, Tsunoda T, Yasugi T, Osuga Y, Yoshikawa H, Nishii O,
Yano T, Taketani Y, Nakamura Y. Genome-wide cDNA microarray analysis ofgene-expression profiles involved in ovarian endometriosis. Int J Oncol. 2003,
22(3):551-560.
91.Kawana K, Yasugi T, Yoshikawa H, Kawana Y, Matsumoto K, Nakagawa S, Onda
T, Kikuchi A, Fujii T, Kanda T, Taketani Y. Evidence for the presence of neutralizing
antibodies against human papillomavirus type 6 in infants born to mothers withcondyloma acuminata. Am J Perinatol. 2003, 20(1): 11-16.
92.Okamoto Y, Tanaka YO, Nishida M, Tsunoda H, Yoshikawa H, Itai Y. MR imagingof the uterine cervix: imaging-pathologic correlation.
Radiographics. 2003, 23(2): 425-445.

93. Okuno S, Sato H, Kuriyama-Matsumura K, Tamba M, Wang H, Sohda S, Hamada H,
Yoshikawa H, Kondo T, Bannai S. Role of cystine transport in intracellular glutathionelevel and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer. 2003,
88(6): 951-956.
94. Ohara K, Tsunoda H, Nishida M, Sugahara S, Hashimoto T, Shioyama Y, Hasezawa
K, Yoshikawa H, Akine Y, Itai Y. Use of small pelvic field instead of whole pelvic fieldin postoperative radiotherapy for node-negative, high-risk stages I and II cervicalsquamous cell carcinoma. Int J Gynecol Cancer. 2003, 13(2): 170-176.
95.Yokoyama M, Iwasaka T, Nagata C, Nozawa S, Sekiya S, Hirai Y, Kanazawa K,
Sato S, Hoshiai H, Sugase M, Kawana T, Yoshikawa H. Prognostic factors associatedwith the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan.
Cancer Lett. 2003, 192(2): 171-179.
96. Takizawa S, Nakagawa S, Nakagawa K, Yasugi T, Fujii T, Kugu K, Yano T,
Yoshikawa H, Taketani Y. Abnormal Fhit expression is an independent poor prognostic
factor for cervical cancer. Br J Cancer. 2003, 88(8): 1213-1216.
97. Furuta R, Hirai Y, Katase K, Tate S, Kawaguchi T, Akiyama F, Kato Y, Kumada K,
Iwasaka T, Yaegashi N, Kanazawa K, Yoshikawa H, Kitagawa T. Ectopic chromosome
around centrosome in metaphase cells as a marker of high-risk humanpapillomavirus-associated cervical intraepithelial neoplasias.

Int J Cancer. 2003,

106(2):167-171.
98. Ichikawa Y, Nakauchi T, Sato T, Oki A, Tsunoda H, Yoshikawa H.
Ultrasound diagnosis of uterine arteriovenous fistula associated with placental site
trophoblastic tumor. Ultrasound Obstet Gynecol. 2003, 21(6): 606-608.
99. Matsumoto K, Yasugi T, Nakagawa S, Okubo M, Hirata R, Maeda H, Yoshikawa H,
Taketani Y. Human papillomavirus type 16 E6 variants and HLA class II alleles among
Japanese women with cervical cancer. Int J Cancer, 106(2): 919-922, 2003.

100. Matsumoto K, Yasugi T, Oki A, Hoshiai H, Taketani Y, Kawana T, Yoshikawa H.
Are smoking and chlamydial infection risk factors for CIN?: Different results after
adjustment for HPV DNA and antibodies. Br J Cancer, 89(5):831-833, 2003.
101. Kawana K, Yasugi T, Kanda T, Kino N, Oda K, Okada S, Kawana Y, Nei T,
Takada T, Toyoshima S, Tsuchiya A, Kondo K, Yoshikawa H, Tsutsumi O, Taketani Y.
Safety and immunogenicity of a peptide containing the cross-neutralization epitope of
HPV16L2 administered nasally in healthy volunteers. Vaccine, 21(27-30):4256-4260,
2003.
102. Kita N, Satoh T, Onuki-Tanabe M, Ainoya Y, Yamada N, Oki A, Tsunoda H,
Yoshikawa H. Undifferentiated carcinoma with osteoclast-like multinucleated giant
cells arising in an ovarian mature cystic teratoma. Gynecol Obstet Invest.
2003;56(4):184-7.
103. Minami R, Tsunoda H, Iijima T, Yoshikawa H, Nemori R, Noguchi M.
Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix. Mod
Pathol. 2003 Nov;16(11):1164-1170. 3.642 (2005)
104. Yamamoto K, Yoshikawa H, Shiromizu K, Saito T, Kuzuya K, Tsunematsu R
and Kamura T. Pulmonary metastasectomy for uterine cervical cancer: A multivariate
analysis. Annals of Thoracic Surgery, 77(4): 1179-1182, 2004.
105. Onda T, Kamura T, Ishizuka N, Katsumata N, Fukuda H and Yoshikawa H.
Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive
surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology
Group Study JCOG0206. Jpn J Clin Oncol, 2004 ;34(1):43-45
106. Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa-Kobayashi K,
Yoshikawa H, Arinami T. Proteome analysis reveals elevated serum levels of clusterin
in patients with preeclampsia. Proteomics. 4(2):537-543, 2004.

107. Tanaka YO, Shigemitsu S, Ichikawa Y, Sohda S, Yoshikawa H, Itai Y. Postpartum
MR diagnosis of retained placenta accreta. Eur Radiol. 2004 14(6):945-52.
108. Minaguchi T, Yoshikawa H, Nakagawa S, Yasugi T, Yano T, Iwase H, Mizutani K,
Shiromizu K, Ohmi K, Watanabe Y, Noda K, Nishiu M, Nakamura Y, Taketani Y.
Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine
cervix. Cancer Lett.

210(1):57-62, 2004.

109. Okamoto Y, Tanaka YO, Nishida M, Tsunoda H, Yoshikawa H. Pelvic imaging:
multicystic uterine cervical lesions. Can magnetic resonance imaging differentiate
benignancy from malignancy?
Acta Radiol. 45(1):102-108, 2004.
110. Miki A, Fujii T, Yoshikawa H, Hyodo H, Kanai T, Yamashita T, Yasugi T,
Kozuma S, Taketani Y. A novel method of preoperative autologous blood donation witha large volume of plasma for surgery in gynecologic malignancies. Transfus Apheresis
Sci. 31(1):21-28, 2004.
111. Ohara K, Tsunoda H, Satoh T, Oki A, Sugahara S, Yoshikawa H.

Use of thesmall pelvic field instead of the classic whole pelvic field in postoperative radiotherapy
for cervical cancer: reduction of adverse events. Int. J. Radiation Oncology Biol.
Phys., 60(1): 258–264, 2004
112. Onda T, Katsumata N, Tsunematsu R, Yasugi T, Mushika M, Yamamoto K, Fujii
T, Hirakawa T, Kamura T, Saito T, Yoshikawa H. Cisplatin, Paclitaxel and Escalating
Doses of Doxorubicin (TAP) in Advanced Ovarian Cancer: a Phase I Trial. Jpn J Clin
Oncol. 34(9):540-546, 2004.
113. Tanaka YO, Tsunoda H, Kitagawa Y, Ueno T, Yoshikawa H, Saida Y.
Functioning Ovarian Tumors: Direct and Indirect Findings at MR Imaging.
Radiographics. 24 (Suppl 1): 147-166, 2004.

114. Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle
tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR
findings. J Magn Reson Imaging. 20(6):998-1007, 2004.
115. Nishida M, Tsunoda H, Ichikawa Y, Yoshikawa H. Complete response toirinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell
carcinoma. Int J Clin Oncol. 9(5):403-405, 2004.
116.Takano K, Ichikawa Y, Ueno E, Ohwada M, Suzuki M, Tsunoda H, Miwa M,
Uchida K, Yoshikawa H. Microsatellite instability and expression of mismatch repair
genes in sporadic endometrial cancer coexisting with colorectal or breast cancer. Oncol
Rep. 13(1):11-16, 2005.
117. Onda T, Yoshikawa H, Yasugi T, Yamada M, Matsumoto K, Taketani Y.
Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Carcinoma;
Proposal for Patients Selection. Br J Cancer 92(6):1026-1032 , 2005.
118. Ohara K, Tanaka YO, Tsunoda H, Oki A, Satoh T, Onishi K, Kagei K, Sugahara S,
Hata M, Igaki H, Tokuuye K, Akine Y, Yoshikawa H. Preliminary estimation oftreatment effect on uterine cervical squamous cell carcinoma in terms of tumor
regression rate: comparison between chemoradiotherapy and radiotherapy alone. Radiat
Med. 23(1):25-29, 2005.
119. Abe K, Hamada H, Chen Y-J, Abe A, Watanabe H, Fujiki Y, Yoshikawa H,
Murakami T, Horigome H: Successful management of supraventricular tachycardia ina fetus using fetal magnetocardiography. Fetal Diagn Ther. 20(5):459-462, 2005.
120. Kawasaki A, Hoshi K, Kawano M, Nogami H, Yoshikawa H, Hisano S.
Upregulation of VGLUT2 expression in hypothalamic-neurohypophysial neurons of therat following osmotic challenge.

Eur J Neurosci. 22(3):672-680, 2005.

121. Toyoda M, Satoh T, Takano K, Sato NO, Oki A, Tsunoda H, Yoshikawa H.
Successful diagnosis of thromboembolism before surgery in a woman with clear celladenocarcinoma of the endometrium. Int J Clin Oncol 10(6):444-446, 2005.
122. Ohara K, Oki A, Tanaka YO, Onishi K, Fukumitsu N, Hashimoto T, Satoh T,
Tsunoda H, Hata M, Sugahara S, Tokuuye K, Akine Y, Yoshikawa H. Early
determination of uterine cervical squamous cell carcinoma radioresponse identifies
high- and low-response tumors.
Int J Radiat Oncol Biol Phys. 64(4); 1179-1182, 2006.
123. Matsumoto K, Yasugi T, Oki A, Fujii T, Nagata C, Sekiya S, Hoshiai H, Taketani
Y, Kanda T, Kawana T, Yoshikawa H. IgG antibodies to HPV16, 52, 58 and 6
L1-capsids and spontaneous regression of cervical intraepithelial neoplasia. Cancer
Lett 231(2):309-313, 2006.
124. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, Sakari M,
Takada I, Nakamura T, Metzger D, Chambon P, Kanno J, Yoshikawa H, Kato S.
Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci U S
A. 103(1):224-229, 2006.
125. Tanaka YO, Yamada K, Oki, A, Yoshikawa, H, Minami M. MR findings of smallround cell tumors of the ovary: A report of 5 cases with literature review. J Comput
Assist Tomogr. 30(1): 12-17, 2006.
126. Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous
thromboembolism following major abdominal surgery: a multi-center, prospective
epidemiological study in Japan.

J Thromb Haemost. 4(3): 581-586, 2006.

127. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T, Noguchi M.
Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci.
97(2):106-112, 2006.

128. Watanabe H, Hamada H, Fujiki Y, Takeuchi S, Urushigawa K, Yoshikawa H.
Third nerve palsy and serous retinal detachment with preeclampsia. Hypertens
Pregnancy 25(1): 33-35, 2006.
129. Mori S, Ozaki S, Yasugi T, Yoshikawa H, Taketani Y, Kanda T. Inhibitory
cis-element-mediated decay of human papillomavirus type 16 L1-transcript in
undifferentiated cells. Mol Cell Biochem. 288(1-2): 47-57, 2006
130. Ogura T, Mizukami H, Mimuro J, Madoiwa S, Okada T, Matsushita T, Urabe M,
Kume A, Hamada H, Yoshikawa H, Sakata Y, Ozawa K. Utility of intraperitoneal
administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer. J
Gene Med. 8(8):990-997, 2006
131. Miura S, Matsumoto K, Oki A, Satoh T, Tsunoda H, Yasugi T, Taketani Y,
Yoshikawa H. Do we need a different strategy for HPV screening and vaccination in
East Asia? Int J Cancer, 119(11): 2713-2715, 2006
132. Minaguchi T, Nakagawa S, Takazawa Y, Nei T, Horie K, Fujiwara T, Osuga Y,
Yasugi T, Kugu K, Yano T, Yoshikawa H, Taketani Y. Combined phospho-Akt andPTEN expressions associated with post-treatment hysterectomy after conservativeprogestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of
the endometrium. Cancer Letters, 248(1):112-122 , 2007
133. Kondo K, Ishii Y, Ochi H, Matsumoto T, Yoshikawa H, Kanda T. Neutralizationof HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbitswith synthetic peptides representing segments of the HPV16 minor capsid protein L2
surface region. Virology. 358(2):266-272, 2007
134. Arimoto T, Nakagawa S, Yasugi T, Yoshikawa H, Kawana K, Yano T, Taketani Y.
Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced orrecurrent endometrial carcinoma. Gynecol Oncol. 104(1):32-35, 2007

135. Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda
H, Yamaguchi I, Nagasawa T, Yoshikawa H, Aonuma K. Tissue factor expression as apossible determinant of thromboembolism in ovarian cancer. Br J Cancer.
96(2):290-295, 2007
136. Ohara K, Tsunoda H, Tanaka YO, Onishi K, Nemoto K, Hashimoto T, Fukumitsu
N, Hata M, Sugahara S, Tokuuye K, Yoshikawa H, Akine Y. Explanation for the failureof neoadjuvant chemotherapy to improve outcomes after radiotherapy for locallyadvanced uterine cervical cancer from the standpoint of the tumor regression rate.
Radiat Med 25;53-59, 2007
137. Goto N, Oishi-Tanaka Y, Tsunoda H, Yoshikawa H, Minami M. Magnetic
resonance findings of primary uterine malignant lymphoma. Magn Reson Med Sci.
6(1):7-13, 2007.
138. Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura KI, Nakagawa T,
Shibuya M, Yoshikawa H, Ohneda O. Identification of functional endothelial progenitor
cells suitable for the treatment of ischemic tissue using human umbilical cord blood.
Blood. 110(1):151-160, 2007
139. Tanaka YO, Saida TS, Minami R, Yagi T, Tsunoda H, Yoshikawa H, Minami M.
MR findings of ovarian tumors with hormonal activity, with emphasis on tumors otherthan sex cord-stromal tumors. Eur J Radiol. 32(6):647-653, 2007
140. Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T,
Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N,
Hiura M, Sakamoto A, Tsuda H, Fukunaga M, and Kamura T. Fertility-Sparing
Treatment with Medroxyprogesterone Acetate for Endometrial Carcinoma and AtypicalHyperplasia in Young Women: A Multicenter Phase II Study. J Clin Oncol.
25(19):2798-2803, 2007

141. Okamoto Y, Tanaka YO, Tsunoda H, Yoshikawa H, Minami M. Malignant orborderline mucinous cystic neoplasms have a larger number of loculi than mucinous
cystadenoma: A retrospective study with MR. J Magn Reson Imaging. 26(1):94-99,
2007.
142. Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K,
Tanaka YO, Tsunoda H, Homma S, Yoshikawa H. High incidence of silent venous
thromboembolism before treatment in ovarian cancer. Br J Cancer. 97(8):1053-1057,
2007
143. Onda T, Matsumoto K, Shibata T, Sato A, Fukuda H, Konishi I, Kamura T,
Yoshikawa H; Japan Clinical Oncology Group. Phase III trial of upfront debulking
surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal
cancers: Japan Clinical Oncology Group Study JCOG0602. Jpn J Clin Oncol.
38(1):74-77, 2008.
144. Kondo K, Ochi H, Matsumoto T, Yoshikawa H, Kanda T. Modification of humanpapillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes. J
Med Virol. 80(5):841-846, 2008.
145. Tanaka YO, Tsunoda H, Minami R, Yoshikawa H, Minami M. Carcinosarcoma of
the uterus: MR findings. J Magn Reson Imaging 28(2):434-439, 2008.
146. Satoh T, Matsumoto K, Uno K, Sakurai M, Okada S, Onuki M, Minaguchi T,
Tanaka YO, Homma S, Oki A, Yoshikawa H. Silent venous thromboembolism before
treatment in endometrial cancer and the risk factors. Br J Cancer 99(7):1034-1039,
2008.
147. Ochi H, Kondo K, Matsumoto K, Oki A, Yasugi T, Furuta R, Hirai Y, Yoshikawa
H, Kanda T. Neutralizing antibodies against human papillomavirus types of 16, 18, 31,
52, and 58 in the serum samples from Japanese women with low grade cervicalintraepithelial neoplasia. Clin Vaccine Immunol. 15(10):1536-1540, 2008.

148. Ohara K, Tanaka YO, Oki A, Okamoto Y, Satoh T, Matsumoto K, Yoshikawa H.
Comparison of tumor regression rate of uterine cervical squamous cell carcinoma
during external beam and intracavitary radiotherapy. Radiat Med. 26(9):526-532, 2008
149. Onda T, Kobayashi H, Nakanishi T, Hatae M, Iwasaka T, Konishi I, Shibata T,
Fukuda H, Kamura T, Yoshikawa H: Feasibility study of neoadjuvant chemotherapy
followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal
cancers: Japan Clinical Oncology Group Study JCOG0206, Gynecol. Oncol. 113(1):57-62, 2009.
150. Konno R, Dobbelaere K O, Godeaux O O, Tamura S, Yoshikawa H:
Immunogenicity, reactogenicity and safety of human papillomavirus 16/18
AS04-adjuvanted vaccine in Japanese women: interim analysis of a phase II
double-blind, randomized controlled trial at Month 7. Int J Gynecol Cancer, 19(5):905-911, 2009.
151. Abe K, Shimizu R, Pan X, Hamada H, Yoshikawa H, Yamamoto M: Stem cells of
GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment.
Experimental Hematology, 37(4): 435-445.e1, 2009152. Tanaka YO, Tsunoda H, Sugano M, Satoh T, Yagi H, Minami R, Shiigai M,
Inadome Y, Yoshikawa H, Noguchi M, Minami M: MR and CT findings ofleiomyomatosis peritonealis disseminata with emphasis on assisted reproductive
technology as a risk factor. Br J Radiol, 82(975): e44-47, 2009
153. Onuki M, Matsumoto K, Satoh T, Oki A, Okada S, Minaguchi T, Ochi H, Nakao S,
Someya K, Yamada N, Hamada H, Yoshikawa H; Human papillomavirus infections
among Japanese women: age-related prevalence and type-specific risk for cervicalcancer. Cancer Sciences, 100(7): 1312-1316, 2009.

154. Shimizu Y, Kamoda T, Nagata M, Yoh K, Hashimoto Y, Matsui A, Yoshikawa H,
Yamagata K, Koyama A. Successful pregnancy in a female patient with congenitalchloride diarrhea (CLD) and renal impairment. J Nephrol. 22(6):809-813, 2009.
155. Kondo K, Ishii Y, Mori S, Shimabukuro S, Yoshikawa H, Kanda T. Nuclear
location of minor capsid protein L2 is required for expression of a reporter plasmid
packaged in HPV51 pseudovirions. Virology 394(2): 259-65, 2009
156. Obata-Yasuoka M, Hamada H, Watanabe H, Shimura R, Toyoda M, Yagi H,
Takeshima K, Abe K, Nakamura Y, Ogura T, Fujiki Y, Yoshikawa H; Midtrimester
termination of pregnancy by using gemeprost in combination with laminaria in women
who have previously undergone cesarean section. J Obstet Gynecol Res 35(5):901-905, 2009.
157. Onda T, Yoshikawa H. A phase III randomized trial comparing neoadjuvant
chemotherapy and upfront debulking surgery is indispensable as a basis for changing
the standard treatment of advanced Müllerian cancer. Gynecol Oncol. 114(2):371-372,
2009
158.Onda T, Yoshikawa H, Yasugi T, Matsumoto K and Taketani Y. The Optimal
Debulking After Neoadjuvant Chemotherapy in Ovarian Cancer; Proposal Based on
Interval Look During Upfront Surgery Setting Treatment. Jpn J Clin Oncol. 40(1):36-41, 2010
159. Saito I, Kitagawa R, Fukuda H, Shibata T, Katsumata N, Konishi I, Yoshikawa H,
Kamura T. A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus
Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer
Study Group/Japan Clinical Oncology Group Study (JCOG0505). Jpn J Clin Oncol.
40(1): 90-93, 2010160. Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, Yamaguchi S,
Ochiai K, Takano M, Yokota H, Kawakami Y, Nishimura S, Ogishima D, Nakagawa S,

Kobayashi H, Shiozawa T, Nakanishi T, Kamura T, Konishi I, and Yoshikawa H.
Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A
Proposal for Patient Selection. J Clin Oncol. 28(10):1727-1732, 2010
161. Tanaka YO, Okada S, Yagi T, Satoh T, Oki A, Tsunoda H, Yoshikawa H. MRI of
endometriotic cysts in association with ovarian carcinoma. Am J Roentgenol.
194(2):355-361, 2010.
162. Nagano M, Kimura K, Yamashita T, Ohneda K, Nozawa D, Hamada H,
Yoshikawa H, Ochiai N, Ohneda O. Hypoxia responsive mesenchymal stem cells
derived from human umbilical cord blood are effective for bone repair. Stem Cells Dev.,
19(8):1195-1210, 2010
163. Nagase S, Inoue Y, Umesaki N, Aoki D, Ueda M, Sakamoto H, Kobayashi S,
Kitagawa R, Toita T, Nagao S, Hasegawa K, Fukasawa I, Fujiwara K, Watanabe Y, Ito
K, Niikura H, Iwasaka T, Ochiai K, Katabuchi H, Kamura T, Konishi I, Sakuragi N,
Tanaka T, Hirai Y, Hiramatsu Y, Mukai M, Yoshikawa H, Takano T, Yoshinaga K,
Otsuki T, Sakuma M, Inaba N, Udagawa Y, Yaegashi N. Evidence-based guidelines fortreatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO)
2007 edition. Int J Clin Oncol. 15(2):117-124, 2010
164. Konno R, Tamura S, Dobbelaere K, Yoshikawa H. Efficacy of humanpapillomavirus 16/18 AS04-adjuvanted vaccine in Japanese women aged 20 to 25 years:
interim analysis of a phase 2 double-blind, randomized, controlled trial. Int J Gynecol
Cancer 20(3):404-410, 2010.
165. Matsumoto K, Oki A, Satoh T Okada S, Minaguchi T, Onuki M, Ochi H, Nakao S,
Sakurai M, Abe A, Hamada H, Yoshikawa H. Interleukin-10 -1082 gene polymorphismand susceptibility to cervical cancer among Japanese women. Jpn J Clin Oncol.
40(11):1113-1116, 2010

166. Shibata T, Nagao S, Tai H, Nagatomo S, Hamada H, Yoshikawa H, Suzuki A, andYamamoto Y. Characterization of the acid-alkaline transition in the individual subunitsof human adult and fetal methemoglobins. Biochemistry 148(2):217-229, 2010
167. Konno R, Tamura S, Dobbelaere K, Yoshikawa H. Efficacy of Human
Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to
25 Years: Final Analysis of a Phase 2 Double-Blind, Randomized Controlled Trial.
Int J Gynecol Cancer. 20(5):847-55, 2010.
168. Ogishima H, Ito S, Tsutsumi A, Sugihara M, Goto D, Matsumoto I,
Obata-Yasuoka M, Hamada H, Yoshikawa H, Takahashi H, Murashima A, Sumida T.
High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid
syndrome: a case report. Int J Rheum Dis. 13(3):e32-35, 2010.
169. Saida T, Tanaka YO, Ohara K, Oki A, Sato T, Yoshikawa H, Minami M.
Can MRI predict local control rate of uterine cervical cancer immediately after radiation
therapy? Magn Reson Med Sci. 9(3):141-148, 2010.
170. Konno R, Sagae S, Yoshikawa H, Basu PS, Hanley SJ, Tan JH, Shin HR.
Cervical Cancer Working Group report. Jpn J Clin Oncol. 40 Suppl 1:i44-50, 2010.
171. Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Mitsuhashi A,
Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T,
Yoshikawa H. Tobacco Smoking and Regression of Low-Grade Cervical Abnormalities.
Cancer Sci 101(9):2065-2073, 2010.
172. Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T,
Hachisuga T, Ito K, Uno T, Katsumata N, Komiyama S, Susumu N, Emoto M,
Kobayashi H, Metoki H, Konishi I, Ochiai K, Mikami M, Sugiyama T, Mukai M, Sagae
S, Hoshiai H, Aoki D, Ohmichi M, Yoshikawa H, Iwasaka T, Udagawa Y, Yaegashi N.
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan

Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol. 15(6):531-542, 2010
173. Tran TC, Kimura K, Nagano M, Yamashita T, Ohneda K, Sugimori H, Sato F,
Sakakibara Y, Hamada H, Yoshikawa H, Son HN, Ohneda O. Identification of humanplacenta-derived mesenchymal stem cells involved in re-endothelialization. J Cell
Physiol, 226(1):224-35, 2011174. Fujiwara K, Aotani E, Hamano T, Nagao S, Yoshikawa H, Sugiyama T, Kigawa J,
Aoki D, Katsumata N, Takeuchi M, Suzuki M. A Randomized Phase II/III Trial of 3
Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with
Intravenous Weekly Dose-Dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian
Tube and Primary Peritoneal Cancer. Jpn J Clin Oncol. 41(2):278-282, 2011175. Konno R, Tamura S, Dobbelaere K, Yoshikawa H. Prevalence and type
distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years
old enrolled in a clinical study. Cancer Sci, 102(4):877-882, 2011176. Yagi H, Ogura T, Mizukami H, Urabe M, Hamada H, Yoshikawa H, Ozawa K,
Kume A. Complete restoration of phenylalanine oxidation in phenylketonuria mouse bya self-complementary adeno-associated virus vector. J Gene Medicine, 13(2):114-122.
2011.
177. Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Mitsuhashi A,
Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T,
Yoshikawa H. Predicting the Progression of Cervical Precursor Lesions by Human
Papillomavirus Genotyping: A Prospective Cohort Study. Int J Cancer, 128(12):2898-2910, 2011.
178. Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, Yoshikawa H,
Saida T, Minami M. Ovarian serous surface papillary borderline tumors form sea
anemone-like masses. J Magn Reson Imaging. 33(3):633-640, 2011.

179. Obata-Yasuoka M, Hamada H, Ohara R, Nakao A, Miyazono Y, Yoshikawa H.
Alveolar capillary dysplasia associated with duodenal atresia: Ultrasonographic findingsof enlarged, highly echogenic lungs and gastric dilatation in a third-trimester fetus. J
Obstet Gynecol Res, 37(7):937-939, 2011.
180. Nakamura E, Satoh T, Iwakawa M, Nakawatari M, Oki A, Matsumoto K, Okada S,
Minaguchi T, Yoshikawa H, Imai T. Villin1, a diagnostic marker for endometrial
adenocarcinoma with high grade nuclear atypia. Cancer Biology & Therapy,
12(3):181-190, 2011.
181. Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, Ikeda T,
Ishikawa H, Ishimoto H, Itoh H, Kanayama N, Kasuga Y, Kawabata M, Konishi I,
Matsubara S, Matsuda H, Murakoshi T, Ohkuchi A, Okai T, Saito S, Sakai M, Satoh S,
Sekizawa A, Suzuki M, Takahashi T, Tokunaga A, Tsukahara Y, Yoshikawa H.
Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology(JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition.
J Obstet Gynecol Res, 37(9):1174-1197, 2011182. Tanaka YO, Okada S, Satoh T, Matsumoto K, Saida T, Oki A, Yoshikawa H,
Minami M. Solid non-invasive ovarian masses on MR: Histopathology and a diagnostic
approach. Eur J Radiol. 80(2): e91-e97, 2011.
183. Nagatomo S, Hamada H, Yoshikawa H. The elongation of Fe-His Bond in α
subunit induced by binding of the allosteric effector bezafibrate to hemoglobins.
J Phys Chem B. 115:12971-12977, 2011.
184. Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R,
Mitsuhashi A, Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y,
Kitagawa T, Yoshikawa H. HLA Class II DRB1*1302 1 allele protects against
progression to cervical intraepithelial neoplasia grade 3: A multicenter, prospective,
cohort study. Int J Gynecol Cancer, 22(3):471-478, 2012.

185. Ochi H, Matsumoto K, Kondo K, Oki A, Furuta R, Hirai Y, Yasugi T, Takatsuka
N, Maeda H, Mitsuhashi A, Fujii T, Kawana K, Iwasaka T, Yaegashi N, Watanabe Y,
Nagai Y, Kitagawa T, Kanda T, Yoshikawa H. Do neutralizing antibody responses
generated by human papillomavirus infections favor a better outcome of low-grade
cervical lesions? J Med Virol, 84(7):1128-1134, 2012186. Kitagawa R, Katsumata N, Ando M, Shimizu C, Fujiwara Y, Yoshikawa H, Satoh
T, Nakanishi T, Ushijima K, Kamura T. A multi-institutional phase II trial of paclitaxel
and carboplatin in the treatment of advanced or recurrent cervical cancer. Gynecol.
Oncol. 125(2):307-311, 2012.
187. Takeda T, Wong TF, Adachi T, Ito K, Uehara S, Kanaoka Y, Kamada M,
Kitagawa H, Koseki S, Gomibuchi H, Saito J, Shirasu K, Sueoka K, Sugimoto M,
Suzuki M, Sumi T, Takeda S, Tasaka K, Noguchi Y, Fujii S, Fujii T, Fujiwara M,
Maeda T, Matsumoto K, Momoeda M, Morita M, Yoshimura K, Hirai Y, Kubota T,
Sakuragi N, Kawabata M, Yoshikawa H, Kobayashi H, Yaegashi N. Guidelines foroffice gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan
Association of Obstetricians and Gynecologists 2011 edition. J Obstet Gynaecol Res.
38(4):615-631, 2012.
188. Nagata C, Kobayashi H, Sakata A, Satomi K, Minami Y, Morishita Y, Ohara R,
Yoshikawa H, Arai Y, Nishida M, Noguchi M. Increased expression of OCIA domain
containing 2 during stepwise progression of ovarian mucinous tumor. Pathol Int.
62(7):471-476, 2012.
189. Matsumoto K, Hirai Y, Furuta R, Takatsuka N, Oki A, Yasugi T, Maeda H,
Mitsuhashi A, Fujii T, Kawana K, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y,
Kitagawa T, Yoshikawa H. Subsequent risks for cervical precancer and cancer inwomen with low-grade squamous intraepithelial lesions unconfirmed bycolposcopy-directed biopsy: results from a multicenter, prospective, cohort study. Int J
Clin Oncol, 17(3):233-239, 2012.

190. Inamine M, Nagai Y, Mitsuhashi A, Nagase S, Yaegashi N, Yoshikawa H, Aoki Y.
Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia(CIN) 1 and 2 lesions. Int J Clin Oncol, 17(5):498-504, 2012
191. Obata-Yasuoka M, Hamada H, Yoshikawa H. Impaired glucose tolerance during
pregnancy: Possible risk factor for vaginal/anorectal colonization by group B
Streptococcus. J Obstet Gynecol Res 38(9):1233, 2012
192. Eto T, Saito T, Kasamatsu T, Nakanishi T, Yokota H, Satoh T, Hiura M,
Yoshikawa H, Kamura T, Konishi I. Clinicopathological prognostic factors and the roleof cytoreduction in surgical stage IVb endometrial cancer: A retrospective
multi-institutional analysis of 248 patients in Japan. Gynecol. Oncol. 127(2):338-344,
2012
193. Nakao S, Mori S, Kondo K, Matsumoto K, Yoshikawa H, Kanda T. Monoclonal
antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor
capsid protein L2. Virology 434(1):110-117, 2012.
194. Satoh T, Matsumoto K, Fujii T, Sato O, Gemma N, Onuki M, Saito H, Aoki D,
Hirai Y, Yoshikawa H. Rapid genotyping of carcinogenic human papillomavirus byloop-mediated isothermal amplification using a new automated DNA test (Clinichip
HPV). J Virol Methods, 188(1-2):83-93, 2012
195. Michikami H, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T,
Oki A, Yoshikawa H. Safety and efficacy of substituting nedaplatin after carboplatin
hypersensitivity reactions in gynecologic malignancies. J Obstet Gynecol Res,
39(1):330-335, 2013
196. Mayumi M, Obata-Yasuoka M, Ogura T, Hamada H, Miyazono Y, Yoshikawa H.
Discordance in Pena-Shokeir phenotype/fetal akinesia deformation sequence in a
monoamniotic twin. J Obstet Gynaecol Res. 39(1):344-346, 2013

197. Abe A, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A,
Yoshikawa H. PIK3CA overexpression is a possible prognostic factor for favorable
survival in ovarian clear cell carcinoma. Human Pathology, 44(2):199-207, 2013
198. Fujii T, Takatsuka N, Nagata C, Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi
T, Kawana K, Mitsuhashi A, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y,
Kitagawa T, Yoshikawa H. Association between carotenoids and outcome of cervicalintraepithelial neoplasia: a prospective cohort study. Int J Clin Oncol, 18(6):1091-1101,
2013
199. Yoshikawa H, Ebihara K, Tanaka Y, Noda K. Efficacy of quadrivalent humanpapillomavirus (types 6, 11, 16, and 18) vaccine (GARDASIL®) in Japanese women
aged 18 to 26 years. Cancer Science, 104(4): 465-472, 2013200. Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H,
Onuki M, Minaguchi T, Sakurai H, Yoshikawa H. Incidence of venous
thromboembolism before treatment in cervical cancer and the impact of management on
venous thromboembolism after commencement of treatment. Thrombosis Research,
131(4):e127-132, 2013
201. Matsumoto T, Hiura M, Baba T, Ishiko O, Shiozawa T, Yaegashi N, Kobayashi H,
Yoshikawa H, Kawamura N, Kaku T. Clinical Management of Atypical Polypoid
Adenomyoma of the Uterus. A Clinicopathological Review of 29 Cases. Gynecol
Oncol, 129(1):54-57, 2013202. Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H,
Minami M. Diversity in size and signal intensity in multilocular cystic ovarian masses:
New parameters for distinguishing metastatic from primary mucinous ovarianneoplasms. J Magn Reson Imaging. 38(4):794-801, 2013

203. Katsumata N, Yoshikawa H, Kobayashi H, Saito T, Kuzuya K, Nakanishi T,
Yasugi T, Yaegashi N, Yokota H, Kodama S, Mizunoe T, Hiura M, Kasamatsu T,
Shibata T, Kamura T. Phase III randomized controlled trial of neoadjuvant
chemotherapy plus radical surgery versus radical surgery alone for stages IB2, IIA2, andIIB cervical cancer: A Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer,
108(10):1957-1963, 2013
204. Akiyama-Abe A, Minaguchi T, Nakamura Y, Michikami H, Shikama A, Nakao S,
Sakurai M, Ochi H, Onuki M, Matsumoto K, Satoh T, Oki A, Yoshikawa H. Loss ofPTEN expression is an independent predictor of favorable survival in endometrial
carcinomas. Br J Cancer 109(6):1703-1710, 2013205. Eto T, Saito T, Shimokawa M, Hatae M, Takeshima N, Kobayashi H, Kasamatsu
T, Yoshikawa H, Kamura T, Konishi I. Status of treatment for the overall population ofpatients with stage IVb endometrial cancer, and evaluation of the role of preoperative
chemotherapy: A retrospective multi-institutional study of 426 patients in Japan.
Gynecol. Oncol. 131(3):574-580, 2013206. Takano M, Ochi H, Takei Y, Miyamoto M, Hasumi Y, Kaneta Y, Nakamura K,
Kurosaki A, Satoh T, Fujiwara H, Nagao S, Furuya K, Yokota H, Ito K, Minegishi T,
Yoshikawa H, Fujiwara K, Suzuki M. Surgery for endometrial cancers with suspectedcervical involvement: is radical hysterectomy needed (a GOTIC study)?
Br J Cancer 109(7):1760-1765, 2013

207. Tasaka N, Matsumotoa K, Satoh T, Minaguchi T, Tanaka YO, Sakata A, Noguchi
M, Yoshikawa H.

Therapeutic effect of dienogest on adenosarcoma arising fromendometriosis: a case report. Springerplus, 2;618, 2013

208. Abe K, Hamada H, Yamada T, Obata-Yasuoka M, Minakami H, Yoshikawa H.
Impact of planning of pregnancy in women with epilepsy on seizure control duringpregnancy and on maternal and neonatal outcomes. Seizure-European Journal of
Epilepsy 23(2):112-116, 2014
209. Morikawa A, Ueda K, Takahashi K, Fukunaga M, Iwashita M, Kobayashi Y,
Takechi K, Umezawa S, Terauchi F, Kiguchi K, Aoki D, Nomura H, Yoshikawa H,
Satoh T, Jobo T, Fujiwara H, Takei Y, Kamoi S, Terao Y, Isonishi S.
Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women:
analysis of 41 cases in Japan. Int J Clin Oncol. 19(6):1074-1079, 2014
210. Noguchi R, Abe K, Hamada H, Ogura T, Obata M, Miyazono Y, Yoshikawa H.
Outcomes of patients with prenatally diagnosed agenesis of the corpus callosum inconjunction with ventriculomegaly. Arch Gynecol Obstet. 290(2):237-242, 2014211. Ohara R, Michikami H, Nakamura Y, Sakata A, Sakashita S, Satomi K, Shiba-Ishii
A, Kano J, Yoshikawa H, Noguchi M. Moesin overexpression is a unique biomarker of
adenomyosis. Pathol Int. 64(3):115-122, 2014.
212. Minakami H, Maeda T, Fujii T, Hamada H, Iitsuka Y, Itakura A, Itoh H, Iwashita
M, Kanagawa T, Kanai M, Kasuga Y, Kawabata M, Kobayashi K, Kotani T, Kudo Y,
Makino Y, Matsubara S, Matsuda H, Miura K, Murakoshi T, Murotsuki J, Ohkuchi A,
Ohno Y, Ohshiba Y, Satoh S, Sekizawa A, Sugiura M, Suzuki S, Takahashi T,
Tsukahara Y, Unno N, Yoshikawa H. Guidelines for obstetrical practice in Japan: Japan
Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians
and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol Res.

40(6):1469-1499,

2014.
213. Konno R, Yoshikawa H, Okutani M, Quint W, Pemmaraju S, Lin L, Struyf F.
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against
cervical intraepithelial neoplasia and cervical infection in young Japanese women: open
follow-up of a randomised clinical trial up to four years post-vaccination. Human
Vaccines & Immunotherapeutics, 10(7):1781-1794, 2014

214. Matsumoto K, Yaegashi N, Iwata T, Ariyoshi K, Fujiwara K, Shiroyama Y, Usami
T, Kawano Y, Horie K, Kawano K, Noda K, Yoshikawa H for MINT Study Group
Monitoring the impact of a national HPV vaccination program in Japan (MINT study):
rationale, design and methods. Jpn J Clin Oncol, 44(10):1000-1003, 2014.
215. Satoh T, Aoki Y, Kasamatsu T, Ochiai K, Takano M, Watanabe Y, Kikkawa F,
Takeshima N, Hatae M, Yokota H, Saito T, Yaegashi N, Kobayashi H, Baba T, Kodama
S, Saito T, Sakuragi N, Sumi T, Kamura T and Yoshikawa H. Administration ofstandard-dose BEP regimen (bleomycin + etoposide + cisplatin) is essential fortreatment of ovarian yolk sac tumor. Eur J Cancer, 51(3):340-351, 2015
216. Takeshima K, Nabekura T, Nagamune K, Hamada H, Yoshikawa H, Shibuya A.
Increased CD11b+Gr-1+ cell population in the placenta after infection with Toxoplasma
gondii. Microbiology and Immunology, 59(2):95-98, 2015.
217. Inoue-Toyoda M, Kato K, Nagata K, Yoshikawa H. Glucocorticoids facilitate thetranscription from the human cytomegalovirus major immediate early promoter inglucocorticoid receptor- and nuclear factor-I-like protein-dependent manner. Biochem
Biophys Res Commun, 458(1):180-185, 2015
218. Kato T, Takashima A, Kasamatsu T, Nakamura K, Mizusawa J, Nakanishi T,
Takeshima N, Kamiura S, Onda T, Sumi T, Takano M, Nakai H; Saito T, Fujiwara K,
Yokoyama M, Itamochi H, Takehara K, Yokota H, Mizunoe T, Takeda S, Sonoda K,
Shiozawa T, Kawabata T, Honma S, Fukuda H, Yaegashi N, Yoshikawa H, Konishi I,
Kamura T. Clinical tumor diameter and prognosis of patients with FIGO stage IB1
cervical cancer (JCOG0806-A). Gynecol Oncol, 137(1):34-39, 2015
219. Ebina Y, Yaegashi N, Katabuchi H, Nagase S, Udagawa Y, Hachisuga T, Saito T,
Mikami M, Aoki Y, Yoshikawa H. Japan Society of Gynecologic Oncology (JSGO)
guidelines 2011 for the treatment of uterine cervical cancer. Int J Clin Oncol,
20(2):240-248, 2015

220. Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T,
Nishimura S, Ushijima K, Takano M, Satoh T, and Yoshikawa H. Paclitaxel plus
Carboplatin Versus Paclitaxel plus Cisplatin in Metastatic or Recurrent Cervical
Cancer: The Open-Label Randomized Phase III Trial (JCOG0505), J Clin Oncol,
33(19):2129-2135, 2015
221. Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo
S, Nagai K, Oki A, Morishita Y, Noguchi M, Yoshikawa H. Optimizing biopsy
procedures during colposcopy for women with abnormal cervical cancer screening
results: a multicenter prospective study. Int J Clin Oncol, 20(3):579-585, 2015
222. Sakurai M, Satoh T, Matsumoto K, Michikami H, Nakamura Y, Nakao S, Ochi H,
Onuki M, Minaguchi T, Yoshikawa H. High pretreatment plasma D-dimer levels areassociated with poor prognosis in patients with ovarian cancer independently of venous
thromboembolism and tumor extension. Int J Gynecol Cancer, 25(4):593-598, 2015
223. Satoh T, Onda T, Tsuda H, Kanato K, Kimura A, Kaba H, Shibata T, Fukuda H,
Konishi I, Kamura T, Yaegashi N and Yoshikawa H. A non-randomized verification
study regarding selection of fertility-sparing surgery for patients with epithelial ovariancancer: Japan Clinical Oncology Group Study JCOG1203. Jpn J Clin Oncol,
45(6):595-599, 2015
224. Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T, Yamashita A,
Oda K, Ishikawa M, Kasamatsu T, Onda T, Konishi I, Yoshikawa H, Yaegashi N.
Minimization of curative surgery for treatment of early cervical cancer: A review. Jpn J
Clin Oncol, 45(7):611-6, 2015
225. Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo
S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H. HPV genotyping
for triage of women with abnormal cervical cancer screening results: a multicenterprospective study. Int J Clin Oncol, 20(5):974-981, 2015

226. Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R,
Mitsuhashi A, Kawana K, Fujii T, Iwata T, Hirai Y, Yokoyama M, Yaegashi N,
Watanabe Y, Nagai Y, Yoshikawa H. Human leukocyte antigen class II DRB1*1302
allele protects against cervical cancer: at which step of multistage carcinogenesis?
; Japan HPV And Cervical Cancer (JHACC) Study Group. Cancer Sci.
106(10):1448-1454, 2015
227. Kawasaki A, Okamoto H, Wada A, Ainoya Y, Kita N, Maeyama T, Edamoto N,
Nishiyama H, Tsukamoto S, Joraku A, Waku N, Yoshikawa H. A case of primaryciliary dyskinesia treated with testicular spermatozoa: case report and a review of theliterature. Reprod Med Biol, 14(4):195-200, 2015.
228.Onuki M, Matsumoto K, Sakurai M, Ochi H, Minaguchi T, Satoh T, Yoshikawa H.
Post-treatment HPV testing for residual or recurrent high-grade cervical intraepithelial
neoplasia: a pooled analysis. J Gynecol Oncol, 27(1):e3., 2016229. Tanaka YO, Okada S, Satoh T, Matsumoto K, Saida T, Minami M, Yoshikawa H.
Uterine cervical cancer volumetry using T2- and diffusion-weighted MR images inpatients treated by primary surgery and neoadjuvant chemotherapy. Acta Radiol.
57(3):378-383, 2016
230.Shikama A, Minaguchi T, Matsumoto K, Akiyama-Abe A, Nakamura Y,
Michikami H, Nakao S, Sakurai M, Ochi H, Onuki M, Satoh T, Oki A, Yoshikawa H.
Clinicopathologic implications of DNA mismatch repair status in endometrial
carcinomas. Gynecol Oncol, 140(2):226-233, 2016
231. Ohara R, Obata-Yasuoka M, Abe K, Yagi H, Hamada H, Yoshikawa H. Effect ofhyperemesis gravidarum on gestational diabetes mellitus screening. Int J Gynaecol
Obstet. 132(2):156-158, 2016.

232. Saida T, Tanaka YO, Matsumoto K, Satoh T, Yoshikawa H, Minami M. Revised
FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important
implication for radiologists. Jpn J Radiol, 34(2):117-124, 2016
233. Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H,
Minami M. Differentiation of epithelial ovarian cancer subtypes by use of imaging andclinical data: a detailed analysis. Cancer Imaging 16(1);3-11, 2016
234.Tanaka YO, Okada S, Sakata A, Saida T, Nagai M, Yoshikawa H, Noguchi M,
Minami M. A metastatic ovarian cancer mimicking pregnancy luteoma found during
puerperium. Magn Reson Med Sci, 15(2):149-150, 2016
235. Iguchi-Manaka A, Okumura G, Kojima H, Cho Y, Hirochika R, Bando H, Sato T,
Yoshikawa H, Hara H, Shibuya A, Shibuya K. Increased Soluble CD155 in the Serumof Cancer Patients. PLoS One 11(4):e0152982, 2016.
236. Minaguchi T, Satoh T, Matsumoto K, Sakurai M, Ochi H, Onuki M, Oki A,
Yoshikawa H. Proposal for the selection criteria of secondary cytoreductive surgery inrecurrent epithelial ovarian, tubal, and peritoneal cancers. Int J Clin Oncol,
21(3):573-539, 2016237. Komiyama S, Katabuchi H, Mikami M, Nagase S, Okamoto A, Ito K, Morishige K,
Suzuki N, Kaneuchi M, Yaegashi N, Udagawa Y, Yoshikawa H. Japan Society of
Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including
primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol. 21(3):435-446,
2016
238. Ebina Y, Katabuchi H, Mikami M, Nagase S, Yaegashi N, Udagawa Y, Kato H,
Kubushiro K, Takamatsu K, Ino K, Yoshikawa H. Japan Society of Gynecologic
Oncology guidelines 2013 for the treatment of uterine body neoplasms. Int J Clin
Oncol. 21(3):419-434, 2016

239. Sugiyama T, Okamoto A, Enomoto T, Hamano T, Aotani E, Terao Y, Suzuki N,
Mikami M, Yaegashi N, Kato K, Yoshikawa H, Yokoyama Y, Tanabe H, Nishino K,
Nomura H, Kim JW, Kim BG, Pignata S, Alexandre J, Green J, Isonishi S, Terauchi F,
Fujiwara K, Aoki D. Randomized phase III Trial of irinotecan plus cisplatin comparedwith paclitaxel plus carboplatin as first-line chemotherapy for ovarian clear cell
carcinoma: JGOG3017/GCIG Trial. J Clin Oncol Aug 20;34(24):2881-2887, 2016240. Onda T, Satoh T, Saito T, Kasamatsu T, Nakanishi T, Nakamura K, Wakabayashi
M, Takehara K, Saito M, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M,
Takeshima N, Watanabe Y, Yaegashi N, Konishi I, Kamura T, Yoshikawa H.
Comparison of treatment invasiveness between upfront debulking surgery versus
interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian,tubal, and peritoneal cancers in a phase III randomized trial: Japan Clinical Oncology
Group Study JCOG0602. Eur J Cancer, Sep 64:22-31, 2016
241. Abe K, Hamada H, Fujiki Y, Iiba M, Tenjinnbayashi Y, Yoshikawa H.
Radiological diagnosis of gas gangrene in a fetus at term. Taiwan J Obstet Gynecol.
55(4):582-584, 2016242. Satoh T, Yoshikawa H. Fertility-sparing surgery for early stage epithelial ovariancancer. Jpn J Clin Oncol. 46(8):703-10, 2016
243. Nishio, S, Kitagawa, R, Shibata, T, Yoshikawa, H, Konishi, I, Ushijima, K,
Kamura, T. Prognostic factors from a randomized phase III trial of paclitaxel andcarboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer:
Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1 Cancer Chemotherapy
and Pharmacology, 78(4):785-790, 2016244. Sakurai M, Matsumoto K, Gosho M, Sakata A, Hosokawa Y, Tenjimbayashi Y,
Katoh T, Shikama A, Komiya H, Michikami H, Tasaka N, Akiyama-Abe A, Nakao S,
Ochi H, Onuki M, Minaguchi T, Yoshikawa H, Satoh T. Expression of tissue factor inepithelial ovarian carcinoma is involved in the development of venous
thromboembolism. Int J Gynecol Cancer, 27(1):37-43, 2017245. Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Nagashima M, Saito T,
Ushijima K, Takahashi F, Noda K, Yoshikawa H. Early impact of the Japanese
immunization program implemented before the HPV vaccination crisis. Int J Cancer,
141(8):1704-1706, 2017
246. Liu S, Minaguchi T, Lachkar B, Zhang S, Xu C, Tenjimbayashi Y, Shikama A,
Tasaka N, Akiyama A, Sakurai M, Nakao S, Ochi H, Onuki M, Matsumoto K,
Yoshikawa H, Satoh T. Separate analysis of human papillomavirus E6 and E7
messenger RNAs to predict cervical neoplasia progression. PloS One, 13(2):e0193061,
2018247. Garland SM, Pitisuttithum P, Ngan HYS, Cho CH, Lee CY, Chen CA, Yang YC,
Chu TY, Twu NF, Samakoses R, Takeuchi Y, Cheung TH, Kim SC, Huang LM, Kim
BG, Kim YT, Kim KH, Song YS, alwani S, Kang JH, Sakamoto M, Ryu HS, Bhatla N,
Yoshikawa H, Ellison MC, Han SR, Moeller E, Murata S, Ritter M, Sawata M, Shields
C, Walia A, Perez G, Luxembourg A. Efficacy, immunogenicity, and safety of a
9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian
countries. J Infectious Diseases, 218(1):95-108, 2018248. Lachkar B, Minaguchi T, Akiyama A, Liu S, Zhang S, Xu C, Shikama A, Tasaka N,
Sakurai M, Nakao S, Ochi H, Matsumoto K, Yoshikawa H, Satoh T. Prognostic significanceof PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent
chemoradiotherapy with weekly cisplatin. Medicine (Baltimore). 97(31):e11392, 2018249. Onuki M, Matsumoto K, Tenjimbayashi Y, Tasaka N, Akiyama A, Sakurai M,
Minaguchi T, Oki A, Satoh T, Yoshikawa H. Human papillomavirus genotype andprognosis of cervical cancer: favorable survival of patients with HPV16 positive tumors.
Papillomavirus Research 6:41-45, 2018

250. Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima
K, Kamiura S, Takehara K, Horie K, Tasaka N, Sonoda K, Takei Y, Aoki Y, Katsuyuki
Konnai, Katabuchi H, Nakamura K, Mitsuya Ishikawa, Watari H, Yoshida H,
Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yoshikawa H. Reduction in
HPV16/18 prevalence among young women with high-grade cervical lesions following
the Japanese HPV vaccination program. Cancer Sci, 110(12):3811-3820, 2019251. Kawasaki A, Itagaki H, Tsumagari A, Ijiri H, Yoshikawa, H, Satoh T. Four casesof Mayer-Rokitansky-Küster-Hauser syndrome treated via non-surgical vaginalreconstruction using uterine cervical dilators. The Journal of Obstetrics andGynaecology Research, 46(3):542-546, 2020
252. Onda T, Satoh T, Ogawa G, Saito T, Kasamatsu T, Nakanishi T, Mizutani T,

Takehara K, Okamoto A, Ushijima K, Kobayashi H, Kawana K, Yokota H,
Takano M, Kanao H, Watanabe Y, Yamamoto K, Yaegashi N, Kamura T,
Yoshikawa H. Comparison of survival between primary debulking surgery andneoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers inphase III randomised trial. Eur J Cancer, 130:114-125, 2020.
253. Onuki M, Matsumoto K, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima K,
Kamiura S, Takehara K, Horie K, Tasaka N, Sonoda K, Takei Y, Aoki Y Konnai K,
Katabuchi H, Nakamura K, Ishikawa M, Watari H, Yoshida H, Matsumura N, Nakai H,
Shigeta S, Takahashi F, Noda K, Yaegashi N, Yoshikawa H. HPV genotype attribution
in cervical cancer and precancer: implication for screening and vaccination in Japan.
Cancer Sci, 2020 May 6. doi: 10.1111/cas.14445. [Epub ahead of print]